Prescribing bias and adverse outcomes of esketamine in major depression comorbid substance.

Li DJ, Hsu TW, Changchien TC, Fang YY, Yang FC, Lin HY, Liang CS

Open source

DOI
10.1016/j.jad.2026.122106
Published
2026 Nov 1
Container
Journal of affective disorders
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jad.2026.122106,
  title = {Prescribing bias and adverse outcomes of esketamine in major depression comorbid substance.},
  author = {Li DJ and Hsu TW and Changchien TC and Fang YY and Yang FC and Lin HY and Liang CS},
  year = {2026},
  journal = {Journal of affective disorders},
  doi = {10.1016/j.jad.2026.122106},
  url = {https://doi.org/10.1016/j.jad.2026.122106}
}

RIS

TY  - JOUR
TI  - Prescribing bias and adverse outcomes of esketamine in major depression comorbid substance.
AU  - Li DJ
AU  - Hsu TW
AU  - Changchien TC
AU  - Fang YY
AU  - Yang FC
AU  - Lin HY
AU  - Liang CS
PY  - 2026
JO  - Journal of affective disorders
DO  - 10.1016/j.jad.2026.122106
UR  - https://doi.org/10.1016/j.jad.2026.122106
ER  - 

APA

DJ, L., TW, H., TC, C., YY, F., FC, Y., HY, L., & CS, L. (2026). Prescribing bias and adverse outcomes of esketamine in major depression comorbid substance.. Journal of affective disorders. https://doi.org/10.1016/j.jad.2026.122106

Source records